Well, I think you need to differentiate between two things. Number one is whether they felt there was enough evidence to make certain recommendations on specific language, what that underlying evidence showed, and what the discussion of that committee showed. I think there was a lot of actual positive discussion, if you watched the two days' worth of committee hearings.
Clearly, this is an advisory panel. The FDA is now going to make its determination. The FDA has actually not made a determination on the application yet. We were actually very encouraged by all of the feedback that came from the committee in total.